Evaluating the cost-effectiveness of insulin detemir versus neutral protamine Hagedorn insulin in patients with type 1 or type 2 diabetes in the UK using a short-term modeling approach

Evaluating the cost-effectiveness of insulin detemir versus neutral protamine Hagedorn insulin in patients with type 1 or type 2 diabetes in the UK using a short-term modeling approach

Richard F Pollock,1 Barrie Chubb,2 William J Valentine,1 Simon Heller3 1Health Economics and Outcomes Research, Ossian Health Economics and Communications GmbH, Basel, Switzerland; 2EU-HEOR, Novo Nordisk Limited, Gatwick, UK; 3Department of Oncology & Metabolism, The University of Sheffield,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pollock RF, Chubb B, Valentine WJ, Heller S
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Cost-Benefit Analysis
Insulin
Diabetes Mellitus
Type 1
Type 2
Hypoglycemia
Specialties of internal medicine
RC581-951
Acceso en línea:https://doaj.org/article/79f0012d1c114bc8958c83db718ff9d6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares